- Home
- ILLR vs ALMS Comparison
ILLR vs ALMS Comparison
Compare ILLR & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILLR
- ALMS
- Stock Information
- Founded
- ILLR 2015
- ALMS 2021
- Country
- ILLR United States
- ALMS United States
- Employees
- ILLR N/A
- ALMS N/A
- Industry
- ILLR Investment Managers
- ALMS
- Sector
- ILLR Finance
- ALMS
- Exchange
- ILLR Nasdaq
- ALMS NYSE
- Market Cap
- ILLR 663.4M
- ALMS 652.3M
- IPO Year
- ILLR N/A
- ALMS 2024
- Fundamental
- Price
- ILLR $4.13
- ALMS $11.91
- Analyst Decision
- ILLR
- ALMS Strong Buy
- Analyst Count
- ILLR 0
- ALMS 6
- Target Price
- ILLR N/A
- ALMS $30.40
- AVG Volume (30 Days)
- ILLR 1.3M
- ALMS 68.3K
- Earning Date
- ILLR 11-21-2024
- ALMS 11-19-2024
- Dividend Yield
- ILLR N/A
- ALMS N/A
- EPS Growth
- ILLR N/A
- ALMS N/A
- EPS
- ILLR N/A
- ALMS N/A
- Revenue
- ILLR $46,338,000.00
- ALMS N/A
- Revenue This Year
- ILLR N/A
- ALMS N/A
- Revenue Next Year
- ILLR N/A
- ALMS N/A
- P/E Ratio
- ILLR N/A
- ALMS N/A
- Revenue Growth
- ILLR N/A
- ALMS N/A
- 52 Week Low
- ILLR $0.66
- ALMS $9.54
- 52 Week High
- ILLR $8.86
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- ILLR N/A
- ALMS N/A
- Support Level
- ILLR N/A
- ALMS N/A
- Resistance Level
- ILLR N/A
- ALMS N/A
- Average True Range (ATR)
- ILLR 0.00
- ALMS 0.00
- MACD
- ILLR 0.00
- ALMS 0.00
- Stochastic Oscillator
- ILLR 0.00
- ALMS 0.00
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.